APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Propofol Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Propofol Injection Market Outlook and Growth Opportunities 2026

Report ID 174029140430 December 2025195 pages

Choose your research edition.

Industry ResearchPropofol Injection Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Propofol Injection Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Propofol Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Propofol Injection Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Propofol Injection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Propofol Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Propofol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Propofol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Propofol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Propofol Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Propofol Injection market include Pfizer, B. Braun Medical, AstraZeneca, Wellona Pharma, Rusoma Laboratories, Neon Laboratories Limited, Fresenius Kabi and Centurion Healthcare Private Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Propofol Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Propofol Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Propofol Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Propofol Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Propofol Injection Segment by Company

Pfizer

B. Braun Medical

AstraZeneca

Wellona Pharma

Rusoma Laboratories

Neon Laboratories Limited

Fresenius Kabi

Centurion Healthcare Private Limited

Propofol Injection Segment by Type

Propofol Medium/Long Chain Fat Emulsion Injection

Propofol Emulsion Injection

Propofol Injection Segment by Application

Hospital

Clinic

Other

Propofol Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Propofol Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Propofol Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Propofol Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Propofol Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propofol Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Propofol Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propofol Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Propofol Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Propofol Injection industry.

Chapter 3: Detailed analysis of Propofol Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Propofol Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Propofol Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Propofol Injection Industry Trends Table 2. Propofol Injection Industry Drivers Table 3. Propofol Injection Industry Opportunities and Challenges Table 4. Propofol Injection Industry Restraints Table 5. Global Propofol Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Propofol Injection Revenue Share by Company (2021-2026) Table 7. Global Propofol Injection Sales Volume by Company (Units) & (2021-2026) Table 8. Global Propofol Injection Sales Volume Share by Company (2021-2026) Table 9. Global Propofol Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Propofol Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Propofol Injection Key Company Manufacturing Base & Headquarters Table 12. Global Propofol Injection Company, Product Type & Application Table 13. Global Propofol Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Propofol Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Propofol Medium/Long Chain Fat Emulsion Injection Table 18. Significant Companies of Propofol Emulsion Injection Table 19. Global Propofol Injection Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 20. Global Propofol Injection Sales Volume by Type (2021-2026) & (Units) Table 21. Global Propofol Injection Sales Volume by Type (2027-2032) & (Units) Table 22. Global Propofol Injection Sales Volume Share by Type (2021-2026) Table 23. Global Propofol Injection Sales Volume Share by Type (2027-2032) Table 24. Global Propofol Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Propofol Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Propofol Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Propofol Injection Sales Value Share by Type (2021-2026) Table 28. Global Propofol Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Other Table 32. Global Propofol Injection Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 33. Global Propofol Injection Sales Volume by Application (2021-2026) & (Units) Table 34. Global Propofol Injection Sales Volume by Application (2027-2032) & (Units) Table 35. Global Propofol Injection Sales Volume Share by Application (2021-2026) Table 36. Global Propofol Injection Sales Volume Share by Application (2027-2032) Table 37. Global Propofol Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Propofol Injection Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Propofol Injection Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Propofol Injection Sales Value Share by Application (2021-2026) Table 41. Global Propofol Injection Sales Value Share by Application (2027-2032) Table 42. Global Propofol Injection Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 43. Global Propofol Injection Sales by Region (2021-2026) & (Units) Table 44. Global Propofol Injection Sales Market Share by Region (2021-2026) Table 45. Global Propofol Injection Sales by Region (2027-2032) & (Units) Table 46. Global Propofol Injection Sales Market Share by Region (2027-2032) Table 47. Global Propofol Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Propofol Injection Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Propofol Injection Sales Value Share by Region (2021-2026) Table 50. Global Propofol Injection Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Propofol Injection Sales Value Share by Region (2027-2032) Table 52. Global Propofol Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Propofol Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Propofol Injection Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 55. Global Propofol Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Propofol Injection Sales by Country (2021-2026) & (Units) Table 57. Global Propofol Injection Sales Market Share by Country (2021-2026) Table 58. Global Propofol Injection Sales by Country (2027-2032) & (Units) Table 59. Global Propofol Injection Sales Market Share by Country (2027-2032) Table 60. Global Propofol Injection Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Propofol Injection Sales Value Market Share by Country (2021-2026) Table 62. Global Propofol Injection Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Propofol Injection Sales Value Market Share by Country (2027-2032) Table 64. Pfizer Company Information Table 65. Pfizer Business Overview Table 66. Pfizer Propofol Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Pfizer Propofol Injection Product Portfolio Table 68. Pfizer Recent Development Table 69. B. Braun Medical Company Information Table 70. B. Braun Medical Business Overview Table 71. B. Braun Medical Propofol Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. B. Braun Medical Propofol Injection Product Portfolio Table 73. B. Braun Medical Recent Development Table 74. AstraZeneca Company Information Table 75. AstraZeneca Business Overview Table 76. AstraZeneca Propofol Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. AstraZeneca Propofol Injection Product Portfolio Table 78. AstraZeneca Recent Development Table 79. Wellona Pharma Company Information Table 80. Wellona Pharma Business Overview Table 81. Wellona Pharma Propofol Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Wellona Pharma Propofol Injection Product Portfolio Table 83. Wellona Pharma Recent Development Table 84. Rusoma Laboratories Company Information Table 85. Rusoma Laboratories Business Overview Table 86. Rusoma Laboratories Propofol Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Rusoma Laboratories Propofol Injection Product Portfolio Table 88. Rusoma Laboratories Recent Development Table 89. Neon Laboratories Limited Company Information Table 90. Neon Laboratories Limited Business Overview Table 91. Neon Laboratories Limited Propofol Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Neon Laboratories Limited Propofol Injection Product Portfolio Table 93. Neon Laboratories Limited Recent Development Table 94. Fresenius Kabi Company Information Table 95. Fresenius Kabi Business Overview Table 96. Fresenius Kabi Propofol Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Fresenius Kabi Propofol Injection Product Portfolio Table 98. Fresenius Kabi Recent Development Table 99. Centurion Healthcare Private Limited Company Information Table 100. Centurion Healthcare Private Limited Business Overview Table 101. Centurion Healthcare Private Limited Propofol Injection Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Centurion Healthcare Private Limited Propofol Injection Product Portfolio Table 103. Centurion Healthcare Private Limited Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Propofol Injection Distributors List Table 107. Propofol Injection Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Propofol Injection Product Image Figure 2. Global Propofol Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Propofol Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Propofol Injection Sales (2021-2032) & (Units) Figure 5. Global Propofol Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Propofol Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Propofol Medium/Long Chain Fat Emulsion Injection Image Figure 10. Propofol Emulsion Injection Image Figure 11. Global Propofol Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 12. Global Propofol Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Propofol Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Propofol Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Propofol Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Propofol Injection Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Propofol Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 21. Global Propofol Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Propofol Injection Sales Volume Share by Application (2021-2032) Figure 23. Global Propofol Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Propofol Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Propofol Injection Sales Value Share by Application (2021-2032) Figure 26. Global Propofol Injection Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 27. Global Propofol Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Propofol Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Propofol Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Propofol Injection Sales Value (2021-2032) & (US$ Million) Figure 31. North America Propofol Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Propofol Injection Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Propofol Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Propofol Injection Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Propofol Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Propofol Injection Sales Value (2021-2032) & (US$ Million) Figure 37. South America Propofol Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Propofol Injection Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Propofol Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Propofol Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Propofol Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Propofol Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Propofol Injection Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Propofol Injection Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Propofol Medium/Long Chain Fat Emulsion Injection
  • Propofol Emulsion Injection
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Pfizer
  • B. Braun Medical
  • AstraZeneca
  • Wellona Pharma
  • Rusoma Laboratories
  • Neon Laboratories Limited
  • Fresenius Kabi
  • Centurion Healthcare Private Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Propofol Injection Sales Value (2021-2032)
  4. 1.2.2 Global Propofol Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Propofol Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Propofol Injection Market Dynamics
  1. 2.1 Propofol Injection Industry Trends
  2. 2.2 Propofol Injection Industry Drivers
  3. 2.3 Propofol Injection Industry Opportunities and Challenges
  4. 2.4 Propofol Injection Industry Restraints
3 Propofol Injection Market by Company
  1. 3.1 Global Propofol Injection Company Revenue Ranking in 2025
  2. 3.2 Global Propofol Injection Revenue by Company (2021-2026)
  3. 3.3 Global Propofol Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Propofol Injection Average Price by Company (2021-2026)
  5. 3.5 Global Propofol Injection Company Ranking (2024-2026)
  6. 3.6 Global Propofol Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Propofol Injection Company Product Type and Application
  8. 3.8 Global Propofol Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Propofol Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Propofol Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Propofol Injection Market by Type
  1. 4.1 Propofol Injection Type Introduction
  2. 4.1.1 Propofol Medium/Long Chain Fat Emulsion Injection
  3. 4.1.2 Propofol Emulsion Injection
  4. 4.2 Global Propofol Injection Sales Volume by Type
  5. 4.2.1 Global Propofol Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Propofol Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Propofol Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Propofol Injection Sales Value by Type
  9. 4.3.1 Global Propofol Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Propofol Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Propofol Injection Sales Value Share by Type (2021-2032)
5 Propofol Injection Market by Application
  1. 5.1 Propofol Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Propofol Injection Sales Volume by Application
  6. 5.2.1 Global Propofol Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Propofol Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Propofol Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Propofol Injection Sales Value by Application
  10. 5.3.1 Global Propofol Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Propofol Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Propofol Injection Sales Value Share by Application (2021-2032)
6 Propofol Injection Regional Sales and Value Analysis
  1. 6.1 Global Propofol Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Propofol Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Propofol Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Propofol Injection Sales by Region (2027-2032)
  5. 6.3 Global Propofol Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Propofol Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Propofol Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Propofol Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Propofol Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Propofol Injection Sales Value (2021-2032)
  12. 6.6.2 North America Propofol Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Propofol Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Propofol Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Propofol Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Propofol Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Propofol Injection Sales Value (2021-2032)
  21. 6.9.2 South America Propofol Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Propofol Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Propofol Injection Sales Value Share by Country, 2025 VS 2032
7 Propofol Injection Country-level Sales and Value Analysis
  1. 7.1 Global Propofol Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Propofol Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Propofol Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Propofol Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Propofol Injection Sales by Country (2027-2032)
  6. 7.4 Global Propofol Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Propofol Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Propofol Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Propofol Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Propofol Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Propofol Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Propofol Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Propofol Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Propofol Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Propofol Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Propofol Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Propofol Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Propofol Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Propofol Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Propofol Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Propofol Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Propofol Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Propofol Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Propofol Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Propofol Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Propofol Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Propofol Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Propofol Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Propofol Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Propofol Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Propofol Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Propofol Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Propofol Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Propofol Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Propofol Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Propofol Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Propofol Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Propofol Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Propofol Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Propofol Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Propofol Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Propofol Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Propofol Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Propofol Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Propofol Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Propofol Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Propofol Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Propofol Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Propofol Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Propofol Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Propofol Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Propofol Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Propofol Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Propofol Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Propofol Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Propofol Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Propofol Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Propofol Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Propofol Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Propofol Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Propofol Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Propofol Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Propofol Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Propofol Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Propofol Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Propofol Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Propofol Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Propofol Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Propofol Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Propofol Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Propofol Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Propofol Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Propofol Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Propofol Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Propofol Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Propofol Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Propofol Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Propofol Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Propofol Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Propofol Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Propofol Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Propofol Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Propofol Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Propofol Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Propofol Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Propofol Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Propofol Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Propofol Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Propofol Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Propofol Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Propofol Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Propofol Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Pfizer
  2. 8.1.1 Pfizer Company Information
  3. 8.1.2 Pfizer Business Overview
  4. 8.1.3 Pfizer Propofol Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Pfizer Propofol Injection Product Portfolio
  6. 8.1.5 Pfizer Recent Developments
  7. 8.2 B. Braun Medical
  8. 8.2.1 B. Braun Medical Company Information
  9. 8.2.2 B. Braun Medical Business Overview
  10. 8.2.3 B. Braun Medical Propofol Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 B. Braun Medical Propofol Injection Product Portfolio
  12. 8.2.5 B. Braun Medical Recent Developments
  13. 8.3 AstraZeneca
  14. 8.3.1 AstraZeneca Company Information
  15. 8.3.2 AstraZeneca Business Overview
  16. 8.3.3 AstraZeneca Propofol Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 AstraZeneca Propofol Injection Product Portfolio
  18. 8.3.5 AstraZeneca Recent Developments
  19. 8.4 Wellona Pharma
  20. 8.4.1 Wellona Pharma Company Information
  21. 8.4.2 Wellona Pharma Business Overview
  22. 8.4.3 Wellona Pharma Propofol Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Wellona Pharma Propofol Injection Product Portfolio
  24. 8.4.5 Wellona Pharma Recent Developments
  25. 8.5 Rusoma Laboratories
  26. 8.5.1 Rusoma Laboratories Company Information
  27. 8.5.2 Rusoma Laboratories Business Overview
  28. 8.5.3 Rusoma Laboratories Propofol Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Rusoma Laboratories Propofol Injection Product Portfolio
  30. 8.5.5 Rusoma Laboratories Recent Developments
  31. 8.6 Neon Laboratories Limited
  32. 8.6.1 Neon Laboratories Limited Company Information
  33. 8.6.2 Neon Laboratories Limited Business Overview
  34. 8.6.3 Neon Laboratories Limited Propofol Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Neon Laboratories Limited Propofol Injection Product Portfolio
  36. 8.6.5 Neon Laboratories Limited Recent Developments
  37. 8.7 Fresenius Kabi
  38. 8.7.1 Fresenius Kabi Company Information
  39. 8.7.2 Fresenius Kabi Business Overview
  40. 8.7.3 Fresenius Kabi Propofol Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Fresenius Kabi Propofol Injection Product Portfolio
  42. 8.7.5 Fresenius Kabi Recent Developments
  43. 8.8 Centurion Healthcare Private Limited
  44. 8.8.1 Centurion Healthcare Private Limited Company Information
  45. 8.8.2 Centurion Healthcare Private Limited Business Overview
  46. 8.8.3 Centurion Healthcare Private Limited Propofol Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Centurion Healthcare Private Limited Propofol Injection Product Portfolio
  48. 8.8.5 Centurion Healthcare Private Limited Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Propofol Injection Value Chain Analysis
  2. 9.1.1 Propofol Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Propofol Injection Sales Mode & Process
  6. 9.2 Propofol Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Propofol Injection Distributors
  9. 9.2.3 Propofol Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst